Literature DB >> 15823916

Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice.

Atsuki Fukushima1, Akemi Ozaki, Zhang Jian, Waka Ishida, Kazuyo Fukata, Hisayuki Ueno, Fu-Tong Liu.   

Abstract

PURPOSE: Allergic conjunctivitis is characterized by allergen-specific IgE in the serum and infiltration of eosinophils into the conjunctiva. However, it remains unclear whether early-phase reaction (EPR) mediated by Ag-specific IgE links to late-phase reaction (LPR) in the conjunctiva. We aimed to investigate whether LPR is mediated by either cellular or humoral immune responses.
METHODS: Experimental immune-mediated blepharoconjunctivitis (EC) was induced in C57BL/6 mice by either active immunization or passive immunization by transfer of ragweed (RW)-primed lymphocytes and RW-specific IgE, followed by RW challenge onto the conjunctiva. Transferring RW-primed lymphocytes were prepared from RW-primed splenocytes which were stimulated in vitro with RW for 3 days. Fifteen minutes after RW challenge, clinical findings were evaluated and 24 hr after challenge, the conjunctivas and sera were harvested for histologic analysis and measurement of IgE, respectively.
RESULTS: EPR was most prominent when EC was induced by transfer of RW-specific IgE. EPR was hardly detectable if EC was induced by transfer of RW-primed lymphocytes. Mild EPR was noted when EC was induced by active immunization. LPR, evaluated by infiltration of eosinophils into the conjunctiva, was most severe when EC was induced by transfer of RW-primed lymphocytes. Minimal, but definite LPR was induced when EC was induced by transfer of RW-specific IgE. Intermediate severity of LPR was induced when EC was induced by active immunization.
CONCLUSIONS: LPR in the conjunctiva is dominantly mediated by cellular immune responses, whereas EPR in the conjunctiva is putatively mediated by humoral immune responses. Importantly, LPR in the conjunctiva is inducible by Ag-specific IgE alone, although minute.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823916     DOI: 10.1080/02713680590927560

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

1.  NKT cells are necessary for maximal expression of allergic conjunctivitis.

Authors:  Nancy J Reyes; Elizabeth Mayhew; Peter W Chen; Jerry Y Niederkorn
Journal:  Int Immunol       Date:  2010-05-26       Impact factor: 4.823

2.  Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.

Authors:  A Fukushima; T Sumi; K Fukuda; N Kumagai; T Nishida; H Yagita; H Ueno
Journal:  Br J Ophthalmol       Date:  2006-08-16       Impact factor: 4.638

3.  Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease.

Authors:  R E Smith; N J Reyes; P Khandelwal; S L Schlereth; H S Lee; S Masli; D R Saban
Journal:  J Leukoc Biol       Date:  2016-02-08       Impact factor: 4.962

4.  γδ T cells are required for maximal expression of allergic conjunctivitis.

Authors:  Nancy J Reyes; Elizabeth Mayhew; Peter W Chen; Jerry Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-06       Impact factor: 4.799

5.  Conjunctival macrophages act as antigen-presenting cells in the conjunctiva during the development of experimental allergic conjunctivitis.

Authors:  Waka Ishida; Ken Fukuda; Mina Kajisako; Ayako Takahashi; Tamaki Sumi; Nico van Rooijen; Atsuki Fukushima
Journal:  Mol Vis       Date:  2010-07-10       Impact factor: 2.367

Review 6.  Immune regulatory mechanisms in allergic conjunctivitis: insights from mouse models.

Authors:  Jerry Y Niederkorn
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-10

7.  Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis.

Authors:  Atsuki Fukushima; Tomoko Yamaguchi; Tamaki Sumi; Ken Fukuda; Naoki Kumagai; Teruo Nishida; Masaru Takeuchi; Osamu Taguchi; Hisayuki Ueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-06       Impact factor: 3.535

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.